title: An investigation of the pharmacokinetics, toxicity, and clinical efficacy of Neoral cyclosporin in cystic fibrosis patients.
authors.affiliation: Department of Cardiothoracic Surgery, National Heart and Lung Institute, Harefield Hospital, Middlesex, UK.
authors.forename: G
authors.initials: G
authors.lastname: Mikhail
authors.forename: H
authors.initials: H
authors.lastname: Eadon
authors.forename: N
authors.initials: N
authors.lastname: Leaver
authors.forename: P
authors.initials: P
authors.lastname: Rogers
authors.forename: D
authors.initials: D
authors.lastname: Stephens
authors.forename: N
authors.initials: N
authors.lastname: Banner
authors.forename: A
authors.initials: A
authors.lastname: Khaghani
authors.forename: M
authors.initials: M
authors.lastname: Yacoub
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002648:Child; D016572:Cyclosporine / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000601:surgery*; D005260:Female; D005541:Forced Expiratory Volume; D006084:Graft Rejection / Q000453:epidemiology; D016041:Heart-Lung Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D015994:Incidence; D016040:Lung Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D014797:Vital Capacity
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine